157 related articles for article (PubMed ID: 23152361)
1. Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis.
Nomura M; Kamata M; Kojima H; Hayashi K; Sawada S
Ann Oncol; 2013 Apr; 24(4):1062-6. PubMed ID: 23152361
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Sucralfate Mouth Wash in Prevention of 5-fluorouracil Induced Oral Mucositis: A Prospective, Randomized, Double-Blind, Controlled Trial.
Ala S; Saeedi M; Janbabai G; Ganji R; Azhdari E; Shiva A
Nutr Cancer; 2016; 68(3):456-63. PubMed ID: 27007594
[TBL] [Abstract][Full Text] [Related]
3. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
[TBL] [Abstract][Full Text] [Related]
6. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
[TBL] [Abstract][Full Text] [Related]
7. 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.
Jebb SA; Osborne RJ; Maughan TS; Mohideen N; Mack P; Mort D; Shelley MD; Elia M
Br J Cancer; 1994 Oct; 70(4):732-5. PubMed ID: 7917930
[TBL] [Abstract][Full Text] [Related]
8. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.
Nottage M; McLachlan SA; Brittain MA; Oza A; Hedley D; Feld R; Siu LL; Pond G; Moore MJ
Support Care Cancer; 2003 Jan; 11(1):41-7. PubMed ID: 12527953
[TBL] [Abstract][Full Text] [Related]
9. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.
Hejna M; Köstler WJ; Raderer M; Steger GG; Brodowicz T; Scheithauer W; Wiltschke C; Zielinski CC
Eur J Cancer; 2001 Nov; 37(16):1994-2002. PubMed ID: 11597376
[TBL] [Abstract][Full Text] [Related]
10. Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy.
Baydar M; Dikilitas M; Sevinc A; Aydogdu I
J Natl Med Assoc; 2005 Aug; 97(8):1161-4. PubMed ID: 16173332
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
[TBL] [Abstract][Full Text] [Related]
12. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
Sorensen JB; Skovsgaard T; Bork E; Damstrup L; Ingeberg S
Cancer; 2008 Apr; 112(7):1600-6. PubMed ID: 18300265
[TBL] [Abstract][Full Text] [Related]
14. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
Okuno SH; Woodhouse CO; Loprinzi CL; Sloan JA; LaVasseur BI; Clemens-Schutjer D; Swan D; Axvig C; Ebbert LP; Tirona MR; Michalak JC; Pierson N
Am J Clin Oncol; 1999 Jun; 22(3):258-61. PubMed ID: 10362332
[TBL] [Abstract][Full Text] [Related]
15. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis.
Loprinzi CL; Cianflone SG; Dose AM; Etzell PS; Burnham NL; Therneau TM; Hagen L; Gainey DK; Cross M; Athmann LM
Cancer; 1990 Apr; 65(8):1879-82. PubMed ID: 2180557
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study.
Dazzi C; Cariello A; Giovanis P; Monti M; Vertogen B; Leoni M; Tienghi A; Turci D; Rosti G; Nanni O; Rondoni C; Marangolo M
Ann Oncol; 2003 Apr; 14(4):559-63. PubMed ID: 12649101
[TBL] [Abstract][Full Text] [Related]
17. [Development of "Patient Friendly Formulations" to Counter the Side Effects of Cancer Chemotherapy].
Hanawa T; Kawano Y; Satoh M
Yakugaku Zasshi; 2018; 138(2):169-175. PubMed ID: 29386430
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis.
Malik IA; Moid I; Haq S; Sabih M
J Pain Symptom Manage; 1997 Aug; 14(2):82-7. PubMed ID: 9262037
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis.
Verdi CJ; Garewal HS; Koenig LM; Vaughn B; Burkhead T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jul; 80(1):36-42. PubMed ID: 7552860
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
